Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SANDOZ INC. et al v. UNITED THERAPEUTICS CORPORATION et al
Case Number:
3:19-cv-10170
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 10, 2021
Sandoz Will Get To Search Rival CFO's Phone In Antitrust Row
United Therapeutics Corp. will have to turn over its chief financial officer's text messages for rival drugmaker Sandoz Inc.'s antitrust suit, although Sandoz must also relinquish evidence related to getting government approval of its competing product, a New Jersey federal judge ruled Thursday.
-
July 01, 2020
Sandoz Dodges Sanctions Bid In Antitrust Dispute
A New Jersey federal judge has rebuffed biopharmaceutical company United Therapeutics and infusion pump maker Smiths Medical's bid to impose sanctions on Sandoz and its marketing firm in an antitrust dispute, ruling that they attempted to correct their accidental filing of an unredacted document that revealed trade secrets.
-
January 30, 2020
NJ Court Declines To Toss Sandoz Suit Over Blocked Generic
Sandoz failed Wednesday to win the injunction it was after to halt the maker of a hypertension drug from effectively blocking the sale of its generic version, but it managed to hold off an effort to dismiss the suit altogether.
-
October 16, 2019
Sandoz Revealed Trade Secrets In Antitrust Suit, Court Told
Sandoz Inc. and its marketing firm were hit with a sanctions motion late Tuesday alleging they violated a confidentiality order by revealing trade secrets in an unredacted filing in the case docket for the generic-drug maker's antitrust claims against United Therapeutics Corp.
-
April 17, 2019
BioPharma Firm, Device Maker Blocked Generic, Sandoz Says
Biopharmaceutical firm United Therapeutics Corp. colluded with the only manufacturer of an infusion pump for injecting its brand-name hypertension drug to muscle out Sandoz's generic alternative, Sandoz alleged in New Jersey federal court.